Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilatator responses in rat isolated hearts

British Journal of Pharmacology

Volumn 135, Issue 5, 2002, Pages 1191-1198

  Ford, William R ^a   Honan, Stuart A ^a   White, Richard ^a   Hiley, C Robin ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Anandamide; Coronary vasodilatation; Endocannabinoid receptors; Langendorff heart perfusion; Negative inotropy

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N MORPHOLINO 1H PYRAZOLE 3 CARBOXAMIDE; 2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CAPSAZEPINE; METHANANDAMIDE; PALMIDROL; RECEPTOR SUBTYPE; RIMONABANT; UNCLASSIFIED DRUG; VANILLOID RECEPTOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; DOSE RESPONSE; DRUG EFFECT; DRUG RECEPTOR BINDING; HEART LEFT VENTRICLE PRESSURE; INOTROPISM; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASODILATATION;

EID: 0036193753     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704565     Document Type: Article

References (51)

1. 9-tetra-hydrocannabinol on myocardial contractility
2. Capsazepine: A competitive antagonist of the sensory neurone excitant capsaicin
3. Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes
4. Potentiation of anandamide hypotension by the transport inhibitor, AM404
5. Control of pain initiation by endogenous cannabinoids
6. The third transmembrane helix of the cannabinoid receptor plays a role in the selectivity of aminoalkylindoles for CB2, peripheral cannabinoid receptor
7. A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig bronchus
8. Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist
9. Production and physiological actions of anandamide in the vasculature of the rat kidney
10. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
11. Formation and inactivation of endogenous cannabinoid anandamide in central neurons
12. Anandamide and delta 9-THC dilation of cerebral arterioles is blocked by indomethacin
13. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide
14. Evidence against anandamide as the hyperpolarizing factor mediating the nitric oxide-independent coronary vasodilator effect of bradykinin in the rat
15. Imaging the brain marijuana receptor: Development of a radioligand that binds to cannabinoid CB1 receptors in vivo
16. Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current
17. Characterization of cannabinoid receptors coupled to vasorelaxation by endothelium-derived hyperpolarizing factor
18. Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion
19. Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1)
20. AM630 antagonism of cannabinoid-stimulated [35S]GTP gamma S binding in the mouse brain
21. 9-tetrahydrocannabinol (THC) on the left ventricular function of isolated hearts
22. Cardiovascular effects of 2-arachidonoyl glycerol in anesthetized mice
23. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors
24. Arachidonylethanolamide (anandamide) binds with low affinity to dihydropyridine binding sites in brain membranes
25. Involvement of cannabinoids in the cardioprotection induced by lipopolysaccharide
26. Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors
27. Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse
28. 9-tetrahydrocannabinol in the rat
29. Structure of a cannabinoid receptor and functional expression of the cloned cDNA
30. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
31. Molecular characterization of a peripheral receptor for cannabinoids
32. Effects and interactions of natural cannabinoids on the isolated heart
33. Cannabinoid receptor ligands: Clinical and neuropharmacological considerations, relevant to future drug discovery and development
34. N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor
35. An endogenous cannabinoid as an endothelium-derived vasorelaxant
36. Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation
37. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
38. SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor
39. Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630
40. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): Identification of cannabinoid receptor subtype selective ligands
41. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
42. Effects of cannabinoids on the perfused rat heart
43. 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain
44. Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide
45. Mesenteric vasodilation mediated by endothelial anandamide receptors
46. Endothelium and cannabinoid receptor involvement in levcromakalim vasorelaxation
47. The actions of some cannabinoid receptor ligands in the rat isolated mesenteric artery
48. The actions of the cannabinoid receptor antagonist, SR 141716A, in the rat isolated mesenteric artery
49. Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries
50. The anandamide transport inhibitor AM404 activates vanilloid receptors
51. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide